Publisher: Food and Drug Administration

Published: 2020

This guidance recommends approaches that sponsors of clinical trials can take to increase enrolment of underrepresented populations.

It's specific to sponsors of clinical trials in the US. However, the principles of inclusion can be applied elsewhere, and the information may be of use to those seeking to align their research with international practices and partners.

Click here to view.